Added to YB: 2026-02-02
Pitch date: 2026-01-29
DHR [neutral]
Danaher Corporation
-3.7%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$147.4B
Pitch Price
$219.37
Price Target
N/A
Dividend
0.61%
EV/EBITDA
22.59
P/E
41.46
EV/Sales
6.56
Sector
Life Sciences Tools and Services
Category
growth
A Myriad of Reasons for Conservativeness - Danaher Corporation
DHR (earnings): Q4 core revenue growth 2% vs 3% guide due to equipment headwinds from tariffs & China VBP. 2026 guide maintained at 3-6% core growth, $8.43 EPS (+8%). Mgmt conservative on equipment despite 3 consecutive quarters order growth, citing lack of visibility. Upside from biotech recovery, reshoring capex cycle potential, M&A opportunities.
Read full article (4 min)